Bayer Launches Medical Imaging App Platform for Radiologists
Calantric™ Digital Solutions reportedly offers artificial intelligence (AI)-powered apps, bolsters lesion detection, facilitates triage priorities and enhances workflow efficiency.
Could a new cloud-based suite of imaging apps help radiologists navigate increasing imaging volume in their practices?
Calantric Digital Solutions offer apps that target three key aspects of radiology workflow, according to Bayer, the manufacturer of the new platform. The company said the system includes apps to assist with lesion detection, triage of suspicious findings for expedited review, and automation of routine tasks and measurements.
The artificial intelligence (AI)-powered aspects of the imaging app platform and access to digital tools may be beneficial in improving diagnostic accuracy and efficiency with imaging assessment, according to Ryan K. Lee, MD, MBA, MRMD, chair of the department of radiology with Einstein Healthcare Network in Philadelphia
“AI has the potential to transform health care, and, particularly in medical imaging, it can turn the growing amounts of data into value-adding insights to support radiologists and their teams in their decision-making,” noted Dr. Lee, an associate professor at the Sydney Kimmel College at Thomas Jefferson University.
Offering a variety of applications, ranging from assistance with pulmonary nodule detection to triage of suspected intracerebral hemorrhage, the initial platform for Calantric Digital Solutions is primarily focused on the assessment of thoracic and neurological diseases, according to Bayer. However, the company said it plans to add more disease-specific apps to the platform in the future.
Photon-Counting Computed Tomography: Eleven Takeaways from a New Literature Review
May 27th 2025In a review of 155 studies, researchers examined the capabilities of photon-counting computed tomography (PCCT) for enhanced accuracy, tissue characterization, artifact reduction and reduced radiation dosing across thoracic, abdominal, and cardiothoracic imaging applications.
Emerging AI Mammography Model May Enhance Clarity for Initial BI-RADS 3 and 4 Classifications
May 21st 2025In a study involving over 12,000 Asian women, researchers found that an artificial intelligence (AI) model converted over 83 percent of false positives in patients with initial BI-RADS 3 and 4 assessments into benign BI-RADS categories.
CT Perfusion Study Shows Enhanced Detection of Medium Vessel Occlusions with Emerging AI Software
May 21st 2025The Rapid CTP AI software offered 23 percent greater detection of medium vessel occlusions in comparison to the Viz CTP AI software, according to research presented at the European Stroke (Organization) Conference (ESOC).
